Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-28 21:57:36 - browse：5555

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

knowledge

WSS

An outdated Medicare rule harms dementia patients with anxiety

Medicare Advantage's lean provider networks lead CMS complaints

ASCO Daily Recap: CAR

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

As biotech industry slumps, bioscience job market is upside down

leisure time

Wikipedia

explore

How to save PrEP access — and even expand it

Stopping antidepressants leads to symptoms for 1 in 6 patients

Drug repurposing or repositioning? The language matters

Elevance PBM president out as customers face prescription chaos

Peter Hotez and the public health issue of online harassment

Flagship Pioneering launches a new biotech in two countries

Cancer drug shortages should be causing more outrage

Illumina board agrees to spin off Grail, as divestment plans proceed

Novavax promises a turnaround & Lilly roils the obesity market

FDA approves Moderna’s RSV vaccine, its second licensed product

explore

Finland to offer bird flu vaccine to select groups of people, a possible global first

BIO selects John Crowley as new CEO

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Eli Lilly’s Zepbound improved liver scarring in mid

Despite FDA concern, risk that CAR

BD to buy Edwards patient monitoring unit for $4.2 billion

knowledge

Wikipedia

knowledge

Wikipedia